These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25780963)

  • 1. Marginal vitiligo: an unusual depigmenting disorder.
    Trikha R; McCowan N; Brodell R
    Dermatol Online J; 2014 Dec; 21(3):. PubMed ID: 25780963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic cutaneous lupus erythematosus in vitiligo.
    Johnson H; Bossenbroek NM; Rosenman K; Meehan SA; Robles M; Pomeranz MK
    Dermatol Online J; 2008 Oct; 14(10):10. PubMed ID: 19061609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colocalization of vitiligo and alopecia areata presenting as poliosis.
    Walker A; Mesinkovska NA; Boncher J; Tamburro J; Bergfeld WF
    J Cutan Pathol; 2015 Feb; 42(2):150-4. PubMed ID: 25388912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photolichenoid plaques with associated vitiliginous pigmentary changes.
    Tran K; Hartman R; Tzu J; Meehan S; Sanders SE; Pomeranz MK; Sanchez M
    Dermatol Online J; 2011 Oct; 17(10):13. PubMed ID: 22031639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo--part II: rheological characterization and in vivo assessment through dermatopharmacokinetic and pilot clinical studies.
    Patel HK; Barot BS; Parejiya PB; Shelat PK; Shukla A
    Colloids Surf B Biointerfaces; 2014 Jul; 119():145-53. PubMed ID: 24767976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
    Coskun B; Saral Y; Turgut D
    Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact leukoderma of the scalp or an unusual variant of vitiligo?
    Verma S; Kumar B
    J Dermatol; 2001 Oct; 28(10):554-6. PubMed ID: 11732723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the lymphocytic infiltrate in a case of vitiligo.
    Horn TD; Abanmi A
    Am J Dermatopathol; 1997 Aug; 19(4):400-2. PubMed ID: 9261477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repigmentation of extensive inflammatory vitiligo with raised borders using early and aggressive treatment.
    Gunasekera N; Murphy GF; Sheth VM
    Dermatology; 2015; 230(1):11-5. PubMed ID: 25413601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histopathologic characteristics of trichrome vitiligo.
    Hann SK; Kim YS; Yoo JH; Chun YS
    J Am Acad Dermatol; 2000 Apr; 42(4):589-96. PubMed ID: 10727303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic discoid lupus erythematosus.
    Farley-Loftus R; Elmariah SB; Ralston J; Kamino H; Franks AG
    Dermatol Online J; 2010 Nov; 16(11):1. PubMed ID: 21163152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatoscopy of blue vitiligo.
    Chandrashekar L
    Clin Exp Dermatol; 2009 Jul; 34(5):e125-6. PubMed ID: 19438538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
    Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
    Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo.
    Camacho F; Mazuecos J
    J Drugs Dermatol; 2002 Sep; 1(2):127-31. PubMed ID: 12847735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of lupus erythematosus and vitiligo (author's transl)].
    Forestier JY; Ortonne JP; Thivolet J; Souteyrand P
    Ann Dermatol Venereol; 1981; 108(1):33-8. PubMed ID: 7235502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A figurate papulosquamous variant of inflammatory vitiligo.
    Lee D; Lazova R; Bolognia JL
    Dermatology; 2000; 200(3):270-4. PubMed ID: 10828641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo with inflammatory raised borders, associated with atopic dermatitis.
    Sugita K; Izu K; Tokura Y
    Clin Exp Dermatol; 2006 Jan; 31(1):80-2. PubMed ID: 16309491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we have to pay more attention to vitiligo patients? Peculiar histopathological features of primary cutaneous melanoma preceded by vitiligo.
    Onsun N; Büyükbabani N; Ummetoğlu O; Cebeci F
    J Dermatol; 2009 Nov; 36(11):612-5. PubMed ID: 19878396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color.
    Silverberg JI; Silverberg NB
    J Drugs Dermatol; 2011 May; 10(5):507-10. PubMed ID: 21533297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of a novel topical formulation for vitiligo: compared evaluation of different treatment modalities in 149 patients.
    Buggiani G; Tsampau D; Hercogovà J; Rossi R; Brazzini B; Lotti T
    Dermatol Ther; 2012; 25(5):472-6. PubMed ID: 23046028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.